Tiagabine

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Tiagabine is a novel antiepileptic drug that was designed to block gamma-aminobutyric acid uptake by presynaptic neurons and glial cells. It has been shown to be effective against partial seizures In adults and adolescents. Preliminary pediatric data are also encouraging. This article reviews the available animal and human data on the pharmacokinetics, efficacy, and safety of tiagabine.

Original languageEnglish (US)
Pages (from-to)24-33
Number of pages10
JournalSeminars in Pediatric Neurology
Volume4
Issue number1
DOIs
StatePublished - 1997

Fingerprint

Neuroglia
Anticonvulsants
gamma-Aminobutyric Acid
Seizures
Pharmacokinetics
Pediatrics
Safety
Neurons
tiagabine

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Tiagabine. / Shinnar, Shlomo.

In: Seminars in Pediatric Neurology, Vol. 4, No. 1, 1997, p. 24-33.

Research output: Contribution to journalArticle

Shinnar, Shlomo. / Tiagabine. In: Seminars in Pediatric Neurology. 1997 ; Vol. 4, No. 1. pp. 24-33.
@article{10af6763bb184c7fb5d3917c5da6a330,
title = "Tiagabine",
abstract = "Tiagabine is a novel antiepileptic drug that was designed to block gamma-aminobutyric acid uptake by presynaptic neurons and glial cells. It has been shown to be effective against partial seizures In adults and adolescents. Preliminary pediatric data are also encouraging. This article reviews the available animal and human data on the pharmacokinetics, efficacy, and safety of tiagabine.",
author = "Shlomo Shinnar",
year = "1997",
doi = "10.1016/S1071-9091(97)80006-X",
language = "English (US)",
volume = "4",
pages = "24--33",
journal = "Seminars in Pediatric Neurology",
issn = "1071-9091",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Tiagabine

AU - Shinnar, Shlomo

PY - 1997

Y1 - 1997

N2 - Tiagabine is a novel antiepileptic drug that was designed to block gamma-aminobutyric acid uptake by presynaptic neurons and glial cells. It has been shown to be effective against partial seizures In adults and adolescents. Preliminary pediatric data are also encouraging. This article reviews the available animal and human data on the pharmacokinetics, efficacy, and safety of tiagabine.

AB - Tiagabine is a novel antiepileptic drug that was designed to block gamma-aminobutyric acid uptake by presynaptic neurons and glial cells. It has been shown to be effective against partial seizures In adults and adolescents. Preliminary pediatric data are also encouraging. This article reviews the available animal and human data on the pharmacokinetics, efficacy, and safety of tiagabine.

UR - http://www.scopus.com/inward/record.url?scp=0030934967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030934967&partnerID=8YFLogxK

U2 - 10.1016/S1071-9091(97)80006-X

DO - 10.1016/S1071-9091(97)80006-X

M3 - Article

C2 - 9097364

AN - SCOPUS:0030934967

VL - 4

SP - 24

EP - 33

JO - Seminars in Pediatric Neurology

JF - Seminars in Pediatric Neurology

SN - 1071-9091

IS - 1

ER -